Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

3Q US Biotech VC Investment Balancing Atop Industry's Peak

This article was originally published in Scrip

Executive Summary

The $2.06bn in venture capital that private US biotechnology firms raised during the third quarter almost matched the industry's near record-breaking second quarter total, keeping 2015 VC investment on track to beat 2014 despite a downturn in public biotech valuations that began in the third quarter.


Related Companies